Cardiovascular Systems Inc Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2011 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cardiovascular Systems Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2011 to Q2 2022.
  • Cardiovascular Systems Inc Deferred Tax Assets, Valuation Allowance for the quarter ending June 30, 2022 was $97.5M, a 9.07% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2022 $97.5M +$8.1M +9.07% Jun 30, 2022 10-K 2022-08-18
Q2 2021 $89.4M +$2.02M +2.31% Jun 30, 2021 10-K 2022-08-18
Q2 2020 $87.4M +$8.61M +10.9% Jun 30, 2020 10-K 2022-08-18
Q2 2019 $78.7M +$2.61M +3.43% Jun 30, 2019 10-K 2022-08-18
Q2 2018 $76.1M -$24.9M -24.6% Jun 30, 2018 10-K 2021-08-19
Q2 2017 $101M -$186K -0.18% Jun 30, 2017 10-K 2020-08-20
Q2 2016 $101M +$16.9M +20% Jun 30, 2016 10-K 2019-08-23
Q2 2015 $84.3M +$15.6M +22.7% Jun 30, 2015 10-K 2018-08-23
Q2 2014 $68.7M +$3.89M +6% Jun 30, 2014 10-K 2017-08-24
Q2 2013 $64.8M +$8.35M +14.8% Jun 30, 2013 10-K 2016-08-25
Q2 2012 $56.5M +$4.09M +7.81% Jun 30, 2012 10-K 2014-08-28
Q2 2011 $52.4M Jun 30, 2011 10-K 2013-09-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.